Practical guidance for regulated marketing teams.
Use these resources to sharpen claim discipline, reduce rework, and improve the quality of assets before formal review.
Building a claim evidence library
How to organise claims, approved source language, references, and rewrite options before content production begins.
Read reference approachFair balance readiness
How to make safety and risk information easier to find, compare, and carry forward across asset versions.
See compliance checksWhy resubmissions happen
The upstream causes of rework, including claim drift, evidence mismatch, citation gaps, and weak handoffs.
See solutionMLR handoff checklist
A practical checklist for cleaner review handoffs with source links, rationale, version notes, and unresolved issues.
See workflowRework cost model
How to estimate internal labour drag from avoidable revision loops and manual checking.
Use calculatorProof sprint structure
How to test OmniVynt in 14 days without committing to a full implementation.
Explore sprintBuilt to support regulated teams, not bypass them.
OmniVynt is advisory-only, human-in-the-loop, and designed to support accountable review workflows for regulated life sciences teams.
Human authority retained
OmniVynt supports reviewers with structured findings and rationale. It does not approve, certify, or submit materials.
Explainable findings
Flags are presented with visible rationale and supporting source context to avoid black-box compliance claims.
Workflow traceability
Teams can capture decisions, review notes, source references, and handoff context for better audit readiness.
Canadian readiness
Designed with Canadian regulated life sciences needs in mind, including PIPEDA-conscious workflows and PAAB/IMC context.
Access control
Enterprise deployments can be scoped around roles, permissions, and team workflows.
Clear limitations
The platform is not an MLR replacement, legal advisor, regulatory authority, or autonomous approval system.
Keep claims and assumptions defensible.
OmniVynt helps teams organize product source authority, regulatory guidance, and evidence documents so review-ready assets keep the right support attached.
Product source authority
Product monographs, prescribing information, labels, approved indications, warnings, precautions, and approved claims libraries.
Regulatory and industry guidance
PAAB, IMC, Health Canada, FDA/OPDP, internal SOPs, brand guidance, and market-specific promotional rules.
Evidence documents
Clinical studies, abstracts, approved references, medical information responses, TMAs, guidelines, and substantiation packages.
OmniVynt can help organise and compare source materials, but the suitability of any claim or reference must be determined by qualified reviewers.